Cargando…
Developing a predictive signature for two trial endpoints using the cross-validated risk scores method
The existing cross-validated risk scores (CVRS) design has been proposed for developing and testing the efficacy of a treatment in a high-efficacy patient group (the sensitive group) using high-dimensional data (such as genetic data). The design is based on computing a risk score for each patient an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102911/ https://www.ncbi.nlm.nih.gov/pubmed/34165151 http://dx.doi.org/10.1093/biostatistics/kxaa055 |